1 recruiting, 1 unknown. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Recruiting 1, Unknown 1 |
Follow Decompensated Heart Failure: new trials by email Literature Review of Decompensated Heart Failure trials Research Report on Decompensated Heart Failure
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Colchicine in Acutely Decompensated HFREF Colchicine 0.6 mg, Control/Placebo group - Heart Failure, Decompensated Heart Failure | Phase 4 | Recruiting | University of Virginia | 30 | 2024-06-01 | 2024-05-08 |
| Regional Tolvaptan Registry Tolvaptan, No intervention - Decompensated Heart Failure, Hyponatremia | Phase 4 | Unknown | Cardiology Research UBC | 25 | 2016-05-01 | 2018-08-10 |
Heart Failure (1) · Hyponatremia (1)
Cardiovascular Diseases (1) · Heart Diseases (1) · Metabolic Diseases (1) · Nutritional and Metabolic Diseases (1) · Water-Electrolyte Imbalance (1)
Colchicine (1) · Tolvaptan (1)
Cardiology Research UBC (1) · University of Virginia (1)
Canada (1) · United States (1)
Antonio Abbate, MD (1) · Sean Virani, MD, MSc, MPH, FRCPC (1)